L&Q Notice – Rua Bioscience Limited

LISTING AND QUOTATION NOTICE: NZX MAIN BOARD
RUA BIOSCIENCE LIMITED (“RUA”) ORDINARY SHARES
NZX Limited, Level 1, NZX Centre, 11 Cable Street, PO Box 2959, Wellington 6140, New Zealand
Tel +64 4 472 7599, www.nzx.com


Company:
Rua Bioscience Limited
Issuer Code:
RUA
ISIN:
NZRUAE0004S1
Short Name:
Rua Bioscience
Registered Office: 1 Commerce Place, Awapuni
Gisborne 4071

Website:
www.ruabio.com
Telephone Number:
+64 (6) 390 6938
Financial Year End:
30 June
Nature of Business:
Rua is a New Zealand pharmaceutical company that is aiming to
be a leading producer of cannabinoid derived medicines. The
Company was established in 2017 in part to support local
economic development in Te Tairāwhiti (East Coast) region, and
is a pioneer in the New Zealand medicinal cannabis sector. It was
the first company to obtain a licence to cultivate cannabis for
research purposes and the Company’s co-founder was actively
involved in both the establishment of the key industry association
and the development of the regulatory framework that is now in
place to govern the sector. Rua will operate in the research,
cultivation, extraction and manufacturing parts of the medicinal
cannabis supply chain. Rua operates only in the medicinal part of
the cannabis sector and has no plans to enter the recreational
cannabis market in New Zealand or in any other country.
Directors:
Trevor Burt, (Chairman), Anna Stove, Martin Smith, Brett
Gamble, and Panapa Ehau
Details of Issue:
The Offer consists of 40 million Shares

Quoted Securities at
Completion of Offer:
140,012,225
Minimum Application Amount:
The minimum Application amount for eligible residents in the
Gisborne constituency or shareholder of Waiapu Investment
Limited is 200 Shares.
2,000 shares and thereafter in multiples of 100 shares under the
Priority Offer
Offer Price:
$0.5 per share
Tick Size:
$0.01

Lead Manager:
Co-Manager:
Northington Partners
Forsyth Barr Limited
Auditors:
Pricewaterhouse Coopers
Solicitors:
Lowndes Jordan
Registrar:
Computershare Investor Services Limited
Settlement Status:
NZCDC Settlement System
Product Disclosure Statement
Dated:
25 September 2020
Priority Offer and Broker Firm
Opens
Monday, 5 October 2020
Priority Offer Closes
Tuesday, 13 October 2020
Broker Firm Offer close
Friday, 16 October 2020
Allotment Date:
Wednesday, 21 October 2020
Earliest Mailing of Holder
Notices:
Friday, 23 October 2020
Expected Commencement of
Trading on the NZX Main Board:
Thursday, 22 October 2020




Mark Peterson
Chief Executive Officer
NZX Limited
25 September 2020